Insights from industry-leading experts
Learn about specialty drug coverage, acquisition, and reimbursement from the experts
A 6-part series of expert-led discussions on buy-and-bill
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss the differences among product acquisitions through buy-and-bill, alternative injection or infusion centers, and specialty pharmacy.
Considerations for integration of buy-and-bill within practices
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions offer insights based on their experience integrating buy-and-bill into a medical practice.
Financial considerations associated with acquiring, storing, and administering HCP-administered products
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss what practices should consider from a financial perspective when they are considering buy-and-bill for their practice.
Considerations for inventory management, minimizing waste, and administration
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss their experiences managing inventory, product administration policies and procedures, and other logistical considerations for practices considering buy-and-bill
Implication of the medical benefit for patients
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss the impact that the medical benefit designation has on patients and practices as it relates to acquisition through buy-and-bill.
Considerations for coding and reimbursement practices
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss important components of the coding and reimbursement process, a key part of the buy-and-bill acquisition method.
Acquisition Insights whitepaper
Read a summary of findings from the Acquisition Insights series,
where 4 industry-leading experts discuss key considerations for
practices who want to implement buy-and-bill.
Additional presentations on buy-and-bill from industry experts
Learn about the buy-and-bill method from leading industry experts.
Determining a drug acquisition method
Robert Tobin gives you an overview of the US health care landscape and how to determine if buy-and-bill is the right acquisition method for a patient.
Introduction to the buy-and-bill process
Join Susan Fleecs as she breaks down what to expect during the buy-and-bill process from ordering to reimbursement.
Coding and reimbursement
Christine Mann explains the importance of accurate coding and how it can impact the reimbursement for a drug.
Getting to know the buy-and-bill process for drug acquisition
Watch as 3 experts break down the buy-and-bill process in detail and how it may impact a practice.